Patients and Industry: Starting Our New Life Together in 2023
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. Now more than ever, thanks to the FDA taking the plunge with us, patients have proper validation to ensure that trial design has endpoints and outcomes with meaningful use.
144 
Let's personalize your content